KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Cash & Current Investments: 2017-2024

Historic Cash & Current Investments for Elanco Animal Health (ELAN) over the last 8 years, with Dec 2024 value amounting to $468.0 million.

  • Elanco Animal Health's Cash & Current Investments rose 3.06% to $505.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 24.70%. This contributed to the annual value of $468.0 million for FY2024, which is 32.95% up from last year.
  • Latest data reveals that Elanco Animal Health reported Cash & Current Investments of $468.0 million as of FY2024, which was up 32.95% from $352.0 million recorded in FY2023.
  • Elanco Animal Health's Cash & Current Investments' 5-year high stood at $638.0 million during FY2021, with a 5-year trough of $345.0 million in FY2022.
  • For the 3-year period, Elanco Animal Health's Cash & Current Investments averaged around $388.3 million, with its median value being $352.0 million (2023).
  • In the last 5 years, Elanco Animal Health's Cash & Current Investments soared by 46.62% in 2020 and then crashed by 45.92% in 2022.
  • Elanco Animal Health's Cash & Current Investments (Yearly) stood at $506.0 million in 2020, then grew by 26.09% to $638.0 million in 2021, then tumbled by 45.92% to $345.0 million in 2022, then increased by 2.03% to $352.0 million in 2023, then surged by 32.95% to $468.0 million in 2024.